Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Aspen Pharmacare (APNHY) had Tangible Shareholders Equity of $698.01M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.36B |
|
$1.48B |
|
$5.47B |
|
$7.44B |
|
$1.30B |
|
$1.35B |
|
$1.60B |
|
$2.90B |
|
$4.54B |
|
|
Tangible Shareholders Equity |
$698.01M |
$4.54B |
|
-- |
|
| Cash Flow Statement Financials | |
$333.04M |
|
$-506.54M |
|
$193.83M |
|
$400.88M |
|
$386.27M |
|
$-14.61M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|